NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pinecone Therapeutics

Pinecone Therapeutics

Private
United StatesHealthcare & Life Scienceshttps://pineconetx.com

Last Round

Accelerator

Nov 6, 2025

Company Overview

Pinecone Therapeutics is a biotechnology company that develops one-time gene therapies for severe, inherited metabolic disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B2C

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

gene therapyPropionic Acidemiaone-time gene therapyrare disease therapyinherited metabolic disordersclinical-stage biotechgenetic medicinedisease-modifying therapycell and gene therapyCGTpediatric rare diseaseinborn errors of metabolismtranslational science

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pinecone Therapeutics Comparables

Compare Pinecone Therapeutics with similar companies based on industry and business-model similarity.

Pinecone Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AstraZeneca
77%
HemoShear Therapeutics
77%
Moderna, Inc.
75%

Pinecone Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorNov 6, 2025

Pinecone Therapeutics Investors

Notable investors and investment history

Pinecone Therapeutics investors
InvestorRounds
Deerfield ManagementAccelerator
Cure by DeerfieldAccelerator
Qatar Development BankAccelerator
Qatar Investment AuthorityAccelerator

Pinecone Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pinecone Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pinecone Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersUnited States
Year FoundedN/A
Last FundingNov 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.